Advancing mental health interventions through EHR software & research
Osmind is the platform for clinicians and researchers advancing new life-saving mental health treatments. Today, mental health disorders are one of the leading causes of death worldwide, especially among young adults, and are tied to shortening lifespans. While there have been developments in new psychiatric medications since the first FDA approval in 1954, today there is a growing movement among clinicians, patients, and researchers who are recognizing the need to accelerate new science.
The Osmind treatment platform is currently used by leading interventional mental health practices to safely administer, monitor, and analyze the use of TMS, ECT, ketamine, SPRAVATO®, and psychedelic medicine for people living with moderate to severe mental health conditions. The core EHR technology is precisely developed for interventional treatment workflows and designed to support a strong therapeutic alliance, including journaling tools and assistance with health plan reimbursement, which is a significant access hurdle for millions of patients.
Research from our platform is already helping to set new standards for mental health interventions. In the largest published real-world analysis of ketamine infusion therapy (KIT), we teamed up with Stanford University School of Medicine to share findings in the Journal of Affective Disorders (March 2022).
Osmind is a San Francisco–based public benefit corporation led by scientists, technologists, and psychiatrists. We are backed by top investors DFJ Growth, General Catalyst, Future Ventures, Tiger Global, and Y Combinator.
We are a series B funded Public Benefit Corporation (PBC) building something that actually moves the needle on the global mental health crisis. (See here for an article our cofounder Jimmy wrote about PBC’s.)
We are searching for a VP of Life Sciences to spearhead our scientific strategy at Osmind. In this role, you will play a foundational role in our company by setting the vision for our internal and external-facing scientific R&D. You will take your industry drug development experience and translate that into the strategy for our enterprise product offerings spanning RWE, biomarker discovery, clinical trial recruitment and site selection, and more. You will report directly to the company cofounders and be a core part of the executive leadership team making key strategic decisions.
Let’s transform neuropsychiatry, together.
What you'll do
About us and more
Some candidates may see the list above and feel discouraged because they don't match all the items. Please apply anyway: there's a good chance you also have important skills we’ve missed! We are committed to diversity and building an equitable and inclusive environment for people of all backgrounds and experiences, and we're taking steps to meet that commitment. We especially encourage members of traditionally underrepresented communities to apply, including women, underrepresented people of color, LGBTQ+ people, veterans, and people with disabilities.
Osmind is a public benefit corporation and platform for clinicians and researchers advancing new life-saving mental health treatments. We recently published our first Public Benefit Report that chronicles how our team of scientists, technologists, and psychiatrists have been working to help solve the worldwide mental health crisis, advance responsible innovation and research, and help ensure robust access to care for patients of all backgrounds. Read the report here: https://www.osmind.org/pbc.
There are 22M+ Americans who suffer from treatment-resistant mental health conditions, meaning they’ve failed two or more conventional treatments. Our mission is to further innovative mental health treatments (ranging from FDA-approved psychedelic medicines to neuromodulation to digital therapeutics to novel molecular approaches) for those patients who are suffering the most. We do this by empowering providers, improving patient care, and accelerating research. Our electronic medical records software is used by mental health doctors and their patients across the US. We analyze the data to help the doctors deliver better care and also offer insights to help research and development of new treatments that actually work.
Backed by top-tier investors (e.g. General Catalyst, Future Ventures, Tiger Global, Y Combinator, Jerry Yang, Joshua Kushner, etc.), Osmind’s team consists of mission-driven experts from across tech and healthcare. We're a tight-knit group of intellectually rigorous, highly collaborative, deeply caring, and fun team members. We've been featured in publications such as Forbes and Crunchbase News.